Past Gift Sparks Future Breakthroughs and FDA Approval

Donation made 17 years ago changed the future of cancer research at Moffitt

FDA Approves Enhertu for HER2-Positive Solid Tumors

The announcement makes it the first HER2-directed therapy for multiple cancer types

CDC: Barriers Continue to Keep Vulnerable Women from Accessing Mammograms

Lack of transportation and social isolation are just two factors impacting access to health care

Is Radiation Before Mastectomy Better for Breast Cancer Patients?

Study shows changing order of treatment cuts time delays and improves quality of life

Pancreatic Cancer Is No Match for Tennis Player

82-year-old Graci McGillicuddy is back on the court after surgery and chemotherapy

Malnutrition Plays Role in Treatment Response, Study Shows

Lung cancer patients with recent weight loss had worse response to immunotherapy

Highlighting Moffitt Cancer Center’s Breakthrough Research

Faculty, postdocs and students presenting at the 2024 American Association for Cancer Research annual meeting

Identifying Accelerated Biological Age in Young Colorectal Cancer Patients Could Improve Post-Treatment Care

A small pilot study investigated the difference in biological age between younger and older adult colorectal cancer patients

Study Explores mRNA Vaccine Combo Therapy for Advanced Non-Small Cell Lung Cancer

Investigators study safety and efficacy of mRNA-based cancer vaccine combined with immunotherapy

Endeavor